Edition:
United States

Aeterna Zentaris Inc (AEZS.O)

AEZS.O on Consolidated Issue listed on NASDAQ Capital Market

2.08USD
15 Dec 2017
Change (% chg)

$-0.14 (-6.31%)
Prev Close
$2.22
Open
$2.23
Day's High
$2.23
Day's Low
$2.06
Volume
709,161
Avg. Vol
454,910
52-wk High
$4.25
52-wk Low
$0.78

Chart for

About

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The... (more)

Overall

Beta: 0.87
Market Cap(Mil.): $33.78
Shares Outstanding(Mil.): 16.21
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Aeterna Zentaris Announces Departure Of Interim Chief Financial Officer

* AETERNA ZENTARIS ANNOUNCES DEPARTURE OF INTERIM CHIEF FINANCIAL OFFICER

Dec 08 2017

BRIEF-Aeterna Zentaris’ MAA for Macrilen™ accepted by EMA

* AETERNA ZENTARIS’ MARKETING AUTHORIZATION APPLICATION FOR MACRILEN™ (MACIMORELIN) FOR EVALUATION OF ADULT GROWTH HORMONE DEFICIENCY ACCEPTED BY EUROPEAN MEDICINES AGENCY

Nov 27 2017

BRIEF-Aeterna Zentaris reports Q3 loss per share of $0.61

* Aeterna Zentaris reports third quarter 2017 financial and operating results

Nov 08 2017

BRIEF-Aeterna Zentaris announces appointment of interim chief financial officer

* Aeterna zentaris announces appointment of interim chief financial officer

Sep 25 2017

BRIEF-Altitude Resources says Kuro Coal to acquire 100 pct interest in Elan coal project

* Altitude resources inc - entered into a share sale deed under which Kuro coal Canada will purchase 100% of Elan coal ltd

Sep 05 2017

BRIEF-Aeterna Zentaris reports Q2 loss per share $0.18

* Aeterna Zentaris reports second quarter 2017 financial and operating results

Aug 10 2017

BRIEF-Aeterna Zentaris engages advisors and provides update to shareholders

* Aeterna Zentaris engages advisors and provides update to shareholders

Aug 08 2017

BRIEF-David Dodd responds to claim filed by Aeterna Zentaris

* David Dodd, former CEO of Aeterna Zentaris, responds to claim filed by Aeterna Zentaris against him & Philip Theodore​

Aug 04 2017

BRIEF-Aeterna Zentaris files claim against former CEO, former general counsel

* Aeterna Zentaris commences legal action against David Dodd and Philip Theodore

Aug 03 2017

BRIEF-Aeterna Zentaris says ‍strategic review committee will be chaired by Carolyn Egbert, and includes Michael Cardiff​

* Aeterna Zentaris forms strategic review committee and appoints Michael Ward as CEO

Jul 20 2017

Earnings vs. Estimates